Abdulla Damluji Highlights ASPREE Trial Update
Abdulla A. Damluji, Director of the Cardiovascular Center on Aging at Cleveland Clinic, has shared an insightful thread on X:
“Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial: ESC Journals
Aspirin for primary prevention for older pts = MACE! ”
Read the full article here.
Title: Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial
Authors: Rory Wolfe, Jonathan C Broder, Zhen Zhou, Anne M Murray, Joanne Ryan, Andrew T Chan, Mark R Nelson, Robyn L Woods, Michael E Ernst, Suzanne G Orchard, Brenda Kirpach, Christopher M Reid, Raj C Shah, Nigel Stocks, Karen L Margolis, Johannes T Neumann, Michelle Wilson, Sharyn Fitzgerald, Suzanne E Mahady, Erica M Wood, Shara Ket, Charles B Eaton, Peter Hand, Mobin Malik, Walter P Abhayaratna, Prasanna Venkataraman, Peter Chan, Geoffrey C Cloud, Geoffrey A Donnan, Jeff D Williamson, Andrew M Tonkin
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis